CHR-6494
| CAS No. | 1333377-65-3 | Cat. No. | BCP06799 |
| Name | CHR-6494 | ||
| Synonyms | CHR6494;CHR 6494; | ||
| Formula | C16H16N6 | M. Wt | 292.34 |
| Description | CHR-6494 is a first-in-class Haspin inhibitor with a wide spectrum of anticancer effects. Recent research showed that CHR-6494 reduces H3T3ph levels in a dose-dependent manner and causes a mitotic catastrophe characterized by metaphase misalignment, spindle abnormalities and centrosome amplification. From the cellular standpoint, the identified small-molecule Haspin inhibitor causes arrest in G2/M and subsequently apoptosis. Importantly, ex vivo assays also demonstrate its anti-angiogenetic features; in vivo, it shows antitumor potential in xenografted nude mice without any observed toxicity. | ||
| Pathways | Cell Cycle/DNA Damage | ||
| Targets | Haspin Kinase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.